Ken Griffin Bio Rad Laboratories, Inc. Call Options Transaction History

Citadel Advisors LLC

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$263.97 - $344.64 $26,397 - $34,464	100 Added 1.2%	8,400 $2.81 Million
Q2 2024 Aug 14, 2024	SELL	$268.26 - $339.48 $1.18 Million - $1.49 Million	-4,400 Reduced 34.65%	8,300 $2.27 Million
Q1 2024 May 15, 2024	SELL	$304.11 - $351.99 $4.44 Million - $5.14 Million	-14,600 Reduced 53.48%	12,700 $4.39 Million
Q4 2023 Feb 14, 2024	BUY	$269.37 - $365.04 $781,173 - $1.06 Million	2,900 Added 11.89%	27,300 $8.81 Million
Q3 2023 Nov 14, 2023	SELL	$350.25 - $422.63 $1.86 Million - $2.24 Million	-5,300 Reduced 17.85%	24,400 $8.75 Million
Q2 2023 Aug 14, 2023	BUY	$359.49 - $486.4 $3.45 Million - $4.67 Million	9,600 Added 47.76%	29,700 $11.3 Million
Q1 2023 May 15, 2023	SELL	$418.69 - $503.0 $13.6 Million - $16.3 Million	-32,400 Reduced 61.71%	20,100 $9.63 Million
Q4 2022 Feb 14, 2023	SELL	$351.71 - $456.01 $12.3 Million - $15.9 Million	-34,900 Reduced 39.93%	52,500 $22.1 Million
Q3 2022 Nov 14, 2022	BUY	$412.59 - $563.26 $16.3 Million - $22.3 Million	39,600 Added 82.85%	87,400 $36.5 Million

456

18.2M

19.5K

13.9K

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $8.14B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.